Importantly, current clinical diagnostic algorithms may require adaptation in the future due to novel culprit genes and associated disease entities identified—e.g., GANAB recently described as a new gene in ADPKD (5). This evidence concerns the gene GANAB and autosomal dominant polycystic kidney disease.